Novamass Ltd

Novamass is an ADME/DMPK service provider and the world's leading expert in drug metabolism and CYP related interactions. We focus on the late screening phase decision making, helping our customers to choose the right ADME studies, execute them and interpret the results in order to make right and timely decisions on which molecules to take further and which to kill. Our mission is to reduce time-to-market and cost-of-development of drugs by helping our customers • to understand the nature of their lead molecules • to choose competent drug candidates timely and • improving success rate in the development